Iovance Biotherapeutics saw the highest growth of 1.09% in patent filings and 2.66% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.82% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Iovance Biotherapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Iovance Biotherapeutics has been focused on protecting inventions in United States(US) with ten publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 22% filings and 31% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and China(CN) patent Office are among the top ten patent offices where Iovance Biotherapeutics is filings its patents. Among the top granted patent authorities, Iovance Biotherapeutics has 31% of its grants in United States(US) and 15% in Israel(IL).
Immatics could be the strongest competitor for Iovance Biotherapeutics
Patents related to rare diseases and cell & gene therapy lead Iovance Biotherapeutics's portfolio
Iovance Biotherapeutics has the highest number of patents in rare diseases followed by, cell & gene therapy and nanomedicine. For rare diseases, nearly 55% of patents were filed and 75% of patents were granted in Q2 2024.
Melanoma related patents lead Iovance Biotherapeutics portfolio followed by non-small cell lung cancer, and breast cancer
Iovance Biotherapeutics has highest number of patents in melanoma followed by non-small cell lung cancer, breast cancer, cervical cancer, and bladder carcinoma. For melanoma, nearly 6% of patents were filed and 12% of patents were granted in Q2 2024.
For comprehensive analysis of Iovance Biotherapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
